Clinical applications of proton MR spectroscopy

American Journal of Neuroradiology

Volumn 17, Issue 1, 1996, Pages 1-15

  Castillo, Mauricio ^a   Kwock, Lester ^a   Mukherji, Suresh K ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Brain, magnetic resonance; Magnetic resonance, spectroscopy; Magnetic resonance, tissue characterization; Special reports

Indexed keywords

ALANINE; CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; LITHIUM; MEMBRANE LIPID; N ACETYLASPARTIC ACID; PSYCHOTROPIC AGENT;

ARTICLE; ASTROCYTOMA; BRAIN DISEASE; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN METASTASIS; BRAIN TUMOR; CLINICAL TRIAL; DEGENERATIVE DISEASE; DEMENTIA; DRUG BRAIN LEVEL; ENCEPHALITIS; HEAD AND NECK TUMOR; HEPATIC ENCEPHALOPATHY; HETEROTOPIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENINGIOMA; MULTIPLE SCLEROSIS; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION NECROSIS; SEIZURE;

ADULT; AGED; BRAIN; BRAIN DISEASES; BRAIN NEOPLASMS; CHILD; DIAGNOSIS, DIFFERENTIAL; ENERGY METABOLISM; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS;

EID: 0030050483     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Purcell EM, Torrey HC, Pound RV. Resonance absorption by nuclear magnetic moments in solids. Physiol Rev 1946;69:37-38
2. Bloch R, Hansen WW. Packard M. Nuclear induction. Physiol Rev 1946;69:127
3. Protor WG, Yu FC. The dependence of nuclear magnetic resonance frequency upon chemical shift. Physiol Rev 1950;70:717
4. Lenkinski RE, Schnall MD. MR spectroscopy and the biochemical basis of neurological disease. In: Atlas SW, ed. Magnetic Resonance Imaging of the Brain and Spine. New York: Raven, 1991:1099-1121
5. Bottomley PA, Foster TB, Darrow RB. Depth-resolved surface coil spectroscopy (DRESS) for in-vivo H-1, P-31, and C-13 NMR. J Magn Reson 1984;59:338-342
6. Luyten PR, Marien AJH, Systma B, et al. Solvent suppressed spatially resolved spectroscopy: an approach to high resolution NMR on a whole body MR system. J Magn Reson 1989;9:126-131
7. Frahm J, Bruhn H, Gyngell ML, et al. Localized high resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93
8. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686
9. van der Knaap MS, van der Grond J, van Rijen PC, et al. Age-dependent changes in localized proton and phosphorus MR spectroscopy of the brain. Radiology 1990;176:509-515
10. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine, and choline. NMR Biomed 1991;4:47-52
11. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424-437
12. Sanders JA. Magnetic resonance spectroscopy. In: Orrison WW, Lewine JD, Sanders JA, Harthshorne MF, eds. Functional Brain Imaging. St Louis: Mosby, 1995:419-467
13. van der Knaap MS, Ross B, Valk J. Uses of MR in inborn errors of metabolism. In: Kucharczyk J, Mosely M, Barkovich AJ, eds. Magnetic Resonance Neuroimaging. Boca Raton: CRC Press, 1994:245-318
14. Ceodan S, Parrilla R, Santoro J, Rico M. H-1 NMR detection of cerebral/myo-inositol. FEBS Lett 1985;187:167-172
15. Miller BL, Moats RA, Shonk T, et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437
16. Michealis T, Merboldt KD, Bruhn H, Dipl Math WH, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227
17. Castillo M, Kwock L, Scatliff JH, Gudeman S, Greenwood R. Proton MR spectroscopic characteristics of a presumed giant sub-cortical heterotopia. AJNR Am J Neuroradiol 1993;14:426-429
18. Luyten PR, Marien AJH, Heindel W, et al. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 1990;176:791-799
19. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541-548
20. Gill SS, Thomas DG. Van Bruggen M, et al. Proton MR spectroscopy of intracranial tumors: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504
21. Kugel H, Heindel W, Ernestus RI, Bunke J, du Mesnil R, Friedmann G. Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy. Radiology 1992;183:701-709
22. Demaerel P, Johannik K, Van Hecke P, et al. Localized H-1 NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76
23. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
24. Sijens PE, van Dijk P, Oudkerk M. Correlation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinomas. Magn Reson Med 1994;32:549-555
25. Gober JR. Noninvasive tissue characterization of brain tumor and radiation therapy using magnetic resonance spectroscopy. Neuroimaging Clin North Am 1993;3:779-802
26. Barker PB, Lee RR, McArthur JC. AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995;195:58-64
27. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schanll MD, Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993:186:739-744
28. Chong WK, Sweeny B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MRI findings. Radiology 1993;188:119-124
29. Cortey A, Jarvik JG, Lenkinski RE, Grossman RI, Frank I, Delivoria-Papadopoulos M. Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers. AJNR Am J Neuroradiol 1994;15:1853-1859
30. Shonk TK, Moats RA, Giffored P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995;195:65-72
31. Miller BL, Moats RA, Shonk T. Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993;187:433-437
32. Rango M, Spagnoli D, Tomei G, Bamont F, Scarlato G, Zetta L. Central nervous system Trans-synaptic effects of acute axonal injury: a H-1 magnetic resonance study. Magn Reson Med 1995;33:595-600
33. Bowen BC, Block RE, Sanchez-Ramos J, et al. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR Am J Neuroradiol 1995;16:61-68
34. van der Knaap MS, van der Grond J, Luyten PR, den Hollander JA, Nauta AAP, Valk J. H-1 and P-31 magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann Neurol 1993;31:202-211
35. Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children, findings with localized proton MR spectroscopy. Radiology 1991;181:173-181
36. Tzika AA, Ball WS, Vigneron DB, Dunn RS, Nelson SJ, Kirks DR. Childhood adrenoleukodystrophy: assessment with proton MR spectroscopy. Radiology 1993;189:467-480
37. Marks HG, Caro PA, Wang Z, et al. Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report. Ann Neurol 1991;30:106-110
38. Grodd W, Krageloh-Mann I, Petersen D, Trefz FK, Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 1990;336:437-438
39. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings, AJNR Am J Neuroradiol 1995;16:233-239
40. Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993;14:1119-1137
41. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992;182:19-27
42. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457-463
43. Barker PB, Gillard JH, van Zijl PCM, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994;192:723-732
44. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanick W, Sauter R. Cerebral metabolism in man after acute stroke: new observations using localized proton MR spectroscopy. Magn Reson Med 1989;9:126-131
45. Duijn JH, Matson GB, Maudsley AA, Hugg JW, Weiner MW. Human brain infarction: proton MR spectroscopy. Radiology 1992;183:711-718
46. Behar KL, den Hollander JA, Stromski ME, et al. High-resolution H-1 nuclear magnetic resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci USA 1983;80:4945-4948
47. Marshall VG, Bradley WG, Marshall CE, Bhoopat T, Rhodes RH. Deep white matter infarction: correlation of MR imaging and histopathologic findings. Radiology 1988;167:517-522
48. Sappey-Marinier D, Calabrese G, Hetherington HP, et al. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn Reson Med 1992;26:313-327
49. Sibbitt WL, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. AJNR Am J Neuroradiol 1994;15:923-928
50. Kuzniecky RI, Jackson GD. Magnetic Resonance in Epilepsy. New York: Raven, 1995:289-314
51. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 1994;193:465-472
52. Kuzniecky RI, Jackson GD. Magnetic Resonance in Epilepsy. New York: Raven, 1995:213-324
53. Komoroski RA. Measurement of psychoactive drugs in the human brain in vivo by MR spectroscopy. AJNR Am J Neuroradiol 1993;14:1038-1042
54. Gonzalez RG, Guimaraes AR, Sachs GS, Rosembaum JF, Garwood M. Renshaw PF. Measurement of human brain lithium in vivo by MR spectroscopy. AJNR Am J Neuroradiol 1993;14:1027-1037
55. Sevick RJ, Barkovich AJ, Edwards MSB, et al. Evolution of white matter lesions in neurofibromatosis type 1 : MR findings. AJR Am J Roentgenol 1992;159:171-175
56. Castillo M, Green C, Kwock L, et al. Proton magnetic resonance spectroscopy in patients with NF-1: evaluation of hamartomas and clinical correlation. AJNR Am J Neuroradiol 1995;16:141-147
57. Castillo M, Kwock L, Green C, Schiro S, Wilson JD, Greenwood R. Proton MR spectroscopy in a possible enhancing hamartoma in a patient with neurofibromatosis type 1. AJNR Am J Neuroradiol 1995;16:993-996
58. Barkovich AJ, Kjos BO. Gray matter heterotopias: MR characteristics and correlation with developmental and neurologic manifestations. Radiology 1992;182:493-499
59. Arnold DL, Matthews PM, Francis G. Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Resort Med 1990;14:154-159
60. Gomori JM, Grossman RI, Shields JA, Augsburger JJ, Joseph PM, DeSimeone D. Ocular MR imaging and spectroscopy: an ex vivo study. Radiology 1986;160:201-205
61. Mafee MF, Barany M, Gotsis ED, et al. Potential use of in vivo proton spectroscopy for head and neck lesions. Radiol Clin North Am 1989;27:243-254
62. McKenna WG, Lenkinski RE, Hendrix RA, Vogele KE, Bloch P. The use of magnetic resonance imaging and spectroscopy in the assessment of patients with head and neck and other superficial human malignancies. Cancer 1989;64:2069-2075
63. Johnson M, Selinsky B, Davis M, et al. In vitro NMR evaluation of human thyroid lesions. Invest Radiol 1989;24:666-671
64. Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountformd CE. Proton magnetic resonance and human thyroid neoplasia, I: discrimination between benign and malignant neoplasms. Am J Med 1994;96:383-388